Raymond James & Associates ODONATE THERAPEUTICS INC Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 04, 2020
SELL
N/A
-9,820 Closed
0 $0
Q2 2020

Jul 28, 2020
SELL
N/A
-988 Reduced 9.14%
9,820 $416,000
Q1 2020

Apr 21, 2020
SELL
N/A
-195 Reduced 1.77%
10,808 $298,000
Q4 2019

Feb 12, 2020
BUY
N/A
1,698 Added 18.25%
11,003 $357,000
Q3 2019

Nov 07, 2019
BUY
N/A
9,305 New
9,305 $242,000
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email